These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36016167)

  • 1. High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia.
    Alzabeedi KH; Makhlof RTM; Bakri RA; Ewis AA; Alhamdi HW; Habeebullah TMA; Khogeer AA; Mulla EAA; Roshan SAM; Qabbani FH; Hafez FH; Alqurashi RG; Babalghaith MO; Ghouth AA; Alhazmi MH; Fallatah OM; Badahdah SA; Endergiri DIA; Albarakati BM; Abdelwahab SF
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.
    Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O
    J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.
    Alosaimi MF; Alhetheel A; Aleisa KA; Altwerki AA; Alenezy NM; Almutairi EM; Alothaim LO; Khalid AMA; Alayed KM; Almazyad MA; BinMoammar TA; Alshobaili FA; Al-Shahrani FS; Alsubaie S; Hasanato RM
    Saudi Med J; 2021 Aug; 42(8):853-861. PubMed ID: 34344809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
    Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
    Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia.
    Mahallawi WH; Al-Zalabani AH
    Saudi J Biol Sci; 2021 Mar; 28(3):1697-1701. PubMed ID: 33519277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pre-Vaccination Donated Blood Is Free from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) but Is Rich with Anti-SARS-CoV-2 Antibodies: A Cross-Section Saudi Study.
    Almaeen AH; Alduraywish AA; Ghazy AA; El-Metwally TH; Alayyaf M; Alrayes FH; Alinad AKM; Albulayhid SBH; Aldakhil AR; Taha AE
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.
    Johargy AK
    J Family Community Med; 2009 Sep; 16(3):111-4. PubMed ID: 23012201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Seroprevalence of Anti-SARS-CoV-2 IgM/IgG among Inhabitants of Sakaka City, Aljouf, Saudi Arabia.
    Taha AE; Alduraywish AA; Almaeen AH; El-Metwally TH; Alayyaf M; Mallick A; Abouelkheir M
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
    Hasan M; Moiz B; Qaiser S; Masood KI; Ghous Z; Hussain A; Ali N; Simas JP; Veldhoen M; Alves P; Abidi SH; Ghias K; Khan E; Hasan Z
    PLoS One; 2022; 17(8):e0271259. PubMed ID: 36001587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City.
    Ashshi AM; Alghamdi S; El-Shemi AG; Almdani S; Refaat B; Mohamed AM; Ghazi HO; Azhar EI; Al-Allaf FA
    Virology (Auckl); 2017; 8():1-5. PubMed ID: 28469422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study.
    Jaiswal R; Sharma S; Singla A; Devpura N; Vohra R; Kakkar M; Rijhwani P; Sureka R
    Transfus Apher Sci; 2022 Jun; 61(3):103338. PubMed ID: 34933819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
    Mahallawi WH; Alsarani MA; Aljohani RH; Alluhaibi AA; Alamri TH; Ibrahim NA; Mahallawi KH; Khabourd OF
    Ann Saudi Med; 2022; 42(2):69-74. PubMed ID: 35380058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread.
    Kale P; Patel N; Gupta E; Bajpai M
    Transfus Apher Sci; 2022 Feb; 61(1):103293. PubMed ID: 34686444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of health awareness and knowledge toward SARS-CoV-2 and COVID-19 vaccines among residents of Makkah, Saudi Arabia.
    Alrefaei AF; Almaleki D; Alshehrei F; Kadasah S; ALluqmani Z; Abdulaziz Alotaibi ; Alsulaimani A; Aljuhani A; Alruhaili A
    Clin Epidemiol Glob Health; 2022; 13():100935. PubMed ID: 34934849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of dengue virus serotypes in asymptomatic blood donors reveals the emergence of serotype 4 in Saudi Arabia.
    Ashshi AM
    Virol J; 2017 Jun; 14(1):107. PubMed ID: 28599678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS COV-2- IgG antibodies in blood donors in pandemic - A game changer for policy makers.
    Mahapatra S
    Transfus Clin Biol; 2022 Feb; 29(1):11-15. PubMed ID: 34653615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.